HUP0301964A2 - Protease inhibitors - Google Patents
Protease inhibitorsInfo
- Publication number
- HUP0301964A2 HUP0301964A2 HU0301964A HUP0301964A HUP0301964A2 HU P0301964 A2 HUP0301964 A2 HU P0301964A2 HU 0301964 A HU0301964 A HU 0301964A HU P0301964 A HUP0301964 A HU P0301964A HU P0301964 A2 HUP0301964 A2 HU P0301964A2
- Authority
- HU
- Hungary
- Prior art keywords
- protease inhibitors
- protease
- inhibitors
- Prior art date
Links
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 title 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25250800P | 2000-11-22 | 2000-11-22 | |
| PCT/US2001/051647 WO2003053331A2 (en) | 2000-11-22 | 2001-11-19 | Protease inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0301964A2 true HUP0301964A2 (en) | 2007-02-28 |
| HUP0301964A3 HUP0301964A3 (en) | 2007-09-28 |
Family
ID=22956303
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0301964A HUP0301964A3 (en) | 2000-11-22 | 2001-11-19 | Protease inhibitors |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1392657A4 (en) |
| JP (1) | JP2005513083A (en) |
| KR (1) | KR20040004445A (en) |
| CN (1) | CN1635903A (en) |
| AR (1) | AR034278A1 (en) |
| AU (1) | AU2001298052A1 (en) |
| BR (1) | BR0115473A (en) |
| CA (1) | CA2436850A1 (en) |
| CZ (1) | CZ20031403A3 (en) |
| HU (1) | HUP0301964A3 (en) |
| IL (1) | IL155997A0 (en) |
| MX (1) | MXPA03004542A (en) |
| NO (1) | NO20032328L (en) |
| PL (1) | PL366232A1 (en) |
| UY (1) | UY27032A1 (en) |
| WO (1) | WO2003053331A2 (en) |
| ZA (1) | ZA200303848B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030144175A1 (en) | 1998-12-23 | 2003-07-31 | Smithkline Beecham Corporation | Protease inhibitors |
| US7071184B2 (en) | 2000-03-21 | 2006-07-04 | Smithkline Beecham Corporation | Protease inhibitors |
| AU2001268407A1 (en) * | 2000-06-14 | 2001-12-24 | Smithkline Beecham Corporation | Protease inhibitors |
| JPWO2008149971A1 (en) | 2007-06-08 | 2010-08-26 | 日本ケミファ株式会社 | Treatment or prevention of cerebral aneurysms |
| JPWO2009054454A1 (en) | 2007-10-24 | 2011-03-03 | 国立大学法人 東京医科歯科大学 | Modulator of signal transduction of Toll-like receptor containing cathepsin inhibitor as an active ingredient |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR200101869T2 (en) * | 1998-12-23 | 2002-01-21 | Smithkline Beecham Corporation | Protease Inhibitors. |
| US7071184B2 (en) * | 2000-03-21 | 2006-07-04 | Smithkline Beecham Corporation | Protease inhibitors |
| AU2001268407A1 (en) * | 2000-06-14 | 2001-12-24 | Smithkline Beecham Corporation | Protease inhibitors |
-
2001
- 2001-11-19 PL PL01366232A patent/PL366232A1/en not_active Application Discontinuation
- 2001-11-19 BR BR0115473-7A patent/BR0115473A/en not_active Application Discontinuation
- 2001-11-19 CN CNA018220533A patent/CN1635903A/en active Pending
- 2001-11-19 IL IL15599701A patent/IL155997A0/en unknown
- 2001-11-19 HU HU0301964A patent/HUP0301964A3/en unknown
- 2001-11-19 WO PCT/US2001/051647 patent/WO2003053331A2/en not_active Application Discontinuation
- 2001-11-19 MX MXPA03004542A patent/MXPA03004542A/en unknown
- 2001-11-19 JP JP2003554091A patent/JP2005513083A/en not_active Withdrawn
- 2001-11-19 CZ CZ20031403A patent/CZ20031403A3/en unknown
- 2001-11-19 KR KR10-2003-7006807A patent/KR20040004445A/en not_active Application Discontinuation
- 2001-11-19 AU AU2001298052A patent/AU2001298052A1/en not_active Abandoned
- 2001-11-19 CA CA002436850A patent/CA2436850A1/en not_active Abandoned
- 2001-11-19 EP EP01275089A patent/EP1392657A4/en not_active Withdrawn
- 2001-11-20 AR ARP010105409A patent/AR034278A1/en unknown
- 2001-11-21 UY UY27032A patent/UY27032A1/en not_active Application Discontinuation
-
2003
- 2003-05-16 ZA ZA200303848A patent/ZA200303848B/en unknown
- 2003-05-22 NO NO20032328A patent/NO20032328L/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR034278A1 (en) | 2004-02-18 |
| UY27032A1 (en) | 2002-07-31 |
| CZ20031403A3 (en) | 2003-10-15 |
| KR20040004445A (en) | 2004-01-13 |
| IL155997A0 (en) | 2003-12-23 |
| JP2005513083A (en) | 2005-05-12 |
| MXPA03004542A (en) | 2003-09-10 |
| AU2001298052A1 (en) | 2003-07-09 |
| NO20032328L (en) | 2003-07-02 |
| PL366232A1 (en) | 2005-01-24 |
| WO2003053331A2 (en) | 2003-07-03 |
| ZA200303848B (en) | 2004-06-28 |
| NO20032328D0 (en) | 2003-05-22 |
| CN1635903A (en) | 2005-07-06 |
| EP1392657A4 (en) | 2004-03-10 |
| HUP0301964A3 (en) | 2007-09-28 |
| EP1392657A2 (en) | 2004-03-03 |
| CA2436850A1 (en) | 2003-07-03 |
| WO2003053331A3 (en) | 2003-11-13 |
| BR0115473A (en) | 2004-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU4344101A (en) | Protease inhibitors | |
| GB0125445D0 (en) | Protease Inhibitors | |
| IL215892A0 (en) | Peptidomimetic protease inhibitors | |
| IL153421A0 (en) | Protease inhibitors | |
| EP1235577A4 (en) | Protease inhibitors | |
| EP1232155A4 (en) | Protease inhibitors | |
| IL151087A0 (en) | Protease inhibitors | |
| EP1229915A4 (en) | Protease inhibitors | |
| EP1231921A4 (en) | Protease inhibitors | |
| EP1229912A4 (en) | Protease inhibitors | |
| EP1229914A4 (en) | Protease inhibitors | |
| EP1173429A4 (en) | Protease inhibitors | |
| HK1043534A1 (en) | Protease inhibitors | |
| EP1229911A4 (en) | Protease inhibitors | |
| EP1351930A4 (en) | Protease inhibitors | |
| EP1233771A4 (en) | Protease inhibitors | |
| EP1401453A4 (en) | Protease inhibitors | |
| EP1231923A4 (en) | Protease inhibitors | |
| HUP0301964A3 (en) | Protease inhibitors | |
| IL155961A0 (en) | Cysteine protease inhibitors | |
| EP1232154A4 (en) | Protease inhibitors | |
| EP1231922A4 (en) | Protease inhibitors | |
| AU6407701A (en) | Serine protease inhibitors | |
| GB0009123D0 (en) | Protease inhibitor | |
| ZA200207478B (en) | Protease inhibitors. |